OSE Immunotherapeutics provides an update on ongoing proceedings NANTES, France, July 2, 2025, 8 AM – OSE Immunotherapeutics SA (ISIN:…
GMAC's latest corporate recruiters survey sends promising signal to recent graduates. RESTON, Va., July 1, 2025 /PRNewswire/ -- Even as employers…
17 June 2025 - The International Olympic Committee (IOC), in collaboration with the World Health Organization (WHO), is launching the next…
– Rademikibart significantly improved lung function and asthma control in patients with eosinophilic-driven type 2 asthma – – Rademikibart reduced…
NEW DELHI, June 12, 2025 /PRNewswire/ -- In light of the ongoing extreme weather conditions, Eternal Ltd. (formerly Zomato Ltd.)…
SYDNEY, June 12, 2025 (GLOBE NEWSWIRE) -- Acronis, a global leader in cybersecurity and data protection, today announced a key leadership appointment in…
Presentation to highlight updated six-month clinical results of a hypoimmune-modified primary pancreatic islet cell therapy for patients with type 1…
London, UK, June 07, 2025 (GLOBE NEWSWIRE) -- Amid growing global economic uncertainty and ongoing pressure from fiat currency devaluation,…
VIENNA, June 5, 2025 /PRNewswire/ -- New 100-week data from the ongoing Phase 1/2 study of zigakibart, an investigational anti-APRIL monoclonal…
DUBAI, UAE, June 4, 2025 /PRNewswire/ -- Bybit, the world's second-largest cryptocurrency exchange by trading volume, has been writing a new…